Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.

You can find text and video tutorials here that explain how to use our system.

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

CVR number: 32323502
Tuborg Boulevard 12, 2900 Hellerup

Credit rating

Company information

Official name
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
Established
2012
Company form
Limited company
Industry
  • Expand more icon21Manufacture of basic pharmaceutical products and pharmaceutical preparations

About the company

ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR number: 32323502) is a company from GENTOFTE. The company recorded a gross profit of -44610.5 kEUR in 2023. The operating profit was -44.6 mEUR, while net earnings were -44.5 mEUR. The profitability of the company measured by Return on Assets (ROA) was -199.6 %, which can be considered poor and Return on Equity (ROE) was -1321.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -100 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.

Financial information

See financials

Gross profit (kEUR)

EBIT (kEUR)

Profitability

Solidity

Key figures (kEUR)

See financials
20192020202120222023
Volume
Net sales
Gross profit-1.85-30.40-6.05-8 328.99-44 610.52
EBIT- 120.63- 125.71-94.08-8 418.53-44 619.27
Net earnings210.42196.96213.02-8 089.72-44 491.10
Shareholders equity total14 404.2514 601.2114 814.236 724.51-37 766.60
Balance sheet total (assets)14 411.9414 611.6914 821.586 733.387.64
Net debt-5.62-21.65-17.06-11.6337 756.18
Profitability
EBIT-%
ROA1.6 %1.6 %1.8 %-75.1 %-199.6 %
ROE1.5 %1.4 %1.4 %-75.1 %-1321.8 %
ROI1.6 %1.6 %1.8 %-75.2 %-199.7 %
Economic value added (EVA)- 811.60- 830.04- 806.61-9 153.34-44 488.44
Solvency
Equity ratio99.9 %99.9 %100.0 %99.9 %-100.0 %
Gearing-100.0 %
Relative net indebtedness %
Liquidity
Quick ratio1 872.21 394.12 015.2758.70.7
Current ratio1 872.21 394.12 015.2758.70.7
Cash and cash equivalents5.6221.6517.0611.637.64
Capital use efficiency
Trade debtors turnover (days)
Net working capital %
Credit risk
Credit ratingBBBBC

Variable visualization

ROA:-199.6%
Rating: 0/100
-20%
0%
4%
11%
24%
60%
Equity ratio:-100.0%
Rating: 0/100
-1%
21%
50%
81%
99%
100%

Roles

Companies in the same industry

Build time: 2024-07-12T11:31:01.887Z

Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.